Chiang Yu
Publications by Year
Research Areas
Cancer therapeutics and mechanisms, HER2/EGFR in Cancer Research, Angiogenesis and VEGF in Cancer, Cancer Treatment and Pharmacology, Bioactive Compounds and Antitumor Agents
Most-Cited Works
- → Substituted 2,5‘-Bi-1H-benzimidazoles: Topoisomerase I Inhibition and Cytotoxicity(1996)229 cited
- Camptothecin overcomes MDR1-mediated resistance in human KB carcinoma cells.(1991)
- A new mammalian DNA topoisomerase I poison Hoechst 33342: cytotoxicity and drug resistance in human cell cultures.(1993)
- → Minor Groove-Directed and Intercalative Ligand−DNA Interactions in the Poisoning of Human DNA Topoisomerase I by Protoberberine Analogs(1997)110 cited
- → Structure-activity relationships of benzimidazoles and related heterocycles as topoisomerase I poisons(1996)96 cited
- → Discovery of the Pyrrolo[2,1-f][1,2,4]triazine Nucleus as a New Kinase Inhibitor Template(2004)92 cited
- → Coralyne and related compounds as mammalian topoisomerase I and topoisomerase II poisons(1996)90 cited
- → Preclinical Antitumor Activity of BMS-599626, a pan-HER Kinase Inhibitor That Inhibits HER1/HER2 Homodimer and Heterodimer Signaling(2006)79 cited
- → Synthesis and Evaluation of Terbenzimidazoles as Topoisomerase I Inhibitors(1995)67 cited
- → Mutations of Human Topoisomerase IIα Affecting Multidrug Resistance and Sensitivity(1999)58 cited